U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C13H13BrN4S.ClH
Molecular Weight 373.699
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TROVIRDINE HYDROCHLORIDE

SMILES

Cl.BrC1=CC=C(NC(=S)NCCC2=CC=CC=N2)N=C1

InChI

InChIKey=IUQKLSJRANLIKE-UHFFFAOYSA-N
InChI=1S/C13H13BrN4S.ClH/c14-10-4-5-12(17-9-10)18-13(19)16-8-6-11-3-1-2-7-15-11;/h1-5,7,9H,6,8H2,(H2,16,17,18,19);1H

HIDE SMILES / InChI
Trovirdine [LY 300046, LY 300082, PETT 1] is a NNRT inhibitor of HIV-1 RT, which progressed through Phase II trials for the treatment of HIV infection. Trovirdine inhibits HIV-1 RT with an IC50 of 7 nM. Cell culture experiments demonstrated that LY300046 was a potent inhibitor of the replication of HIV-1 in human T-cell lines and human PBL, including spread of the virus from infected to uninfected T cells. It was potent against patient isolates as well as laboratory isolates of HIV-1 but was not active against HIV-2 or simian immunodeficiency virus.

CNS Activity

Curator's Comment: Concentrations of LY300046 in the brain were similar to those in plasma at all of the time points examined, indicating that LY300046 readily crosses the blood-brain barrier in rats.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
7.0 nM [IC50]
PubMed

PubMed

TitleDatePubMed
Phenethylthiazolylthiourea (PETT) compounds as a new class of HIV-1 reverse transcriptase inhibitors. 2. Synthesis and further structure-activity relationship studies of PETT analogs.
1996 Oct 11
Structure-based design of N-[2-(1-piperidinylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea and N-[2-(1-piperazinylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea as potent non-nucleoside inhibitors of HIV-1 reverse transcriptase.
1998 Aug 18
Structure-based design of non-nucleoside reverse transcriptase inhibitors of drug-resistant human immunodeficiency virus.
1999 Sep
Structure-based design, parallel synthesis, structure-activity relationship, and molecular modeling studies of thiocarbamates, new potent non-nucleoside HIV-1 reverse transcriptase inhibitor isosteres of phenethylthiazolylthiourea derivatives.
2005 Jun 2
Patents

Sample Use Guides

Rats were administered a single 20-mg/kg oral dose of Trovirdine [LY 300046].
Route of Administration: Oral
In Vitro Use Guide
Trovirdine inhibits HIV-1 RT with an IC50 of 7 nM when employing heteropolymeric primer/template (oligo-DNA/ribosomal RNA)and dGTP as substrate.
Name Type Language
TROVIRDINE HYDROCHLORIDE
Common Name English
TROVIRDINE HCL
Common Name English
THIOUREA, N-(5-BROMO-2-PYRIDINYL)-N'-(2-(2-PYRIDINYL)ETHYL)-, HYDROCHLORIDE (1:1)
Systematic Name English
LY-300046 HYDROCHLORIDE
Code English
Code System Code Type Description
PUBCHEM
5327620
Created by admin on Fri Dec 15 17:35:14 GMT 2023 , Edited by admin on Fri Dec 15 17:35:14 GMT 2023
PRIMARY
FDA UNII
70714531RJ
Created by admin on Fri Dec 15 17:35:14 GMT 2023 , Edited by admin on Fri Dec 15 17:35:14 GMT 2023
PRIMARY
CAS
148311-89-1
Created by admin on Fri Dec 15 17:35:14 GMT 2023 , Edited by admin on Fri Dec 15 17:35:14 GMT 2023
PRIMARY